Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin pharmacokinetics in pleural empyema and complicated parapneumonic effusion
NL-OMON24554Not yet recruiting
- Sponsor
- Not applicable.
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of amoxicillin and clavulanic acid in Empyema Thoracis and Complicated parapneumonic effusion (cPPE) (2 arms), sponsored by Not applicable. Primary endpoint: Probability of target attainment in pleural fluid. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
amoxicillinclavulanic acid
03
Conditions
Empyema ThoracisComplicated parapneumonic effusion (cPPE)
Beyond the preview
Go deeper on NL-OMON24554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24554.